Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 11, Pages 6047
Publisher
MDPI AG
Online
2021-06-03
DOI
10.3390/ijms22116047
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Doubling up on function: dual-specificity tyrosine-regulated kinase 1A (DYRK1A) in B cell acute lymphoblastic leukemia
- (2021) Jung-Hyun Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3
- (2021) Rahul S. Bhansali et al. JOURNAL OF CLINICAL INVESTIGATION
- Properties of FDA-approved small molecule protein kinase inhibitors: a 2021 update
- (2021) Robert Roskoski PHARMACOLOGICAL RESEARCH
- TROAP switches DYRK1 activity to drive hepatocellular carcinoma progression
- (2021) Lei Li et al. Cell Death & Disease
- Multi-influential genetic interactions alter behaviour and cognition through six main biological cascades in Down syndrome mouse models
- (2021) Arnaud Duchon et al. HUMAN MOLECULAR GENETICS
- DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes
- (2021) Kunal Kumar et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis
- (2021) Y. Yazici et al. OSTEOARTHRITIS AND CARTILAGE
- Oncogenic B-Myb Is Associated With Deregulation of the DREAM-Mediated Cell Cycle Gene Expression Program in High Grade Serous Ovarian Carcinoma Clinical Tumor Samples
- (2021) Audra N. Iness et al. Frontiers in Oncology
- Dual Specificity Kinase DYRK3 Promotes Aggressiveness of Glioblastoma by Altering Mitochondrial Morphology and Function
- (2021) Kyeongmin Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Progesterone Receptors Promote Quiescence & Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube Models
- (2021) Laura J Mauro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A subcellular map of the human kinome
- (2021) Haitao Zhang et al. eLife
- Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup® Dietary Supplement: Role of Green Tea Catechins
- (2020) Yuchen Gu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor
- (2020) Kunal Kumar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133
- (2020) Yahu A. Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Conserved Kinase-Based Body-Temperature Sensor Globally Controls Alternative Splicing and Gene Expression
- (2020) Tom Haltenhof et al. MOLECULAR CELL
- Leishmania dual‐specificity tyrosine‐regulated kinase 1 (DYRK1) is required for sustaining Leishmania stationary phase phenotype
- (2020) Vinícius Pinto Costa Rocha et al. MOLECULAR MICROBIOLOGY
- Two drugs converged in a pancreatic β cell
- (2020) Marissa A. Scavuzzo et al. Science Translational Medicine
- GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration
- (2020) Courtney Ackeifi et al. Science Translational Medicine
- Altered Hippocampal-Prefrontal Neural Dynamics in Mouse Models of Down Syndrome
- (2020) Pishan Chang et al. Cell Reports
- The Natural Metabolite 4-Cresol Improves Glucose Homeostasis and Enhances β-Cell Function
- (2020) Francois Brial et al. Cell Reports
- Host factor prioritization for pan-viral genetic perturbation screens using random intercept models and network propagation
- (2020) Simon Dirmeier et al. PLoS Computational Biology
- Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases
- (2020) Alejandro Correa-Sáez et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Overexpression of miR-26a-5p suppresses Tau phosphorylation and Aβ accumulation in Alzheimer's disease mice by targeting DYRK1A
- (2020) Yanni Liu et al. CURRENT NEUROVASCULAR RESEARCH
- Impairment of DYRK2 by DNMT1‑mediated transcription augments carcinogenesis in human colorectal cancer
- (2020) Tomotaka Kumamoto et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Characterization of unconventional kinetochore kinases KKT10 and KKT19 in Trypanosoma brucei
- (2020) Midori Ishii et al. JOURNAL OF CELL SCIENCE
- DYRK kinase Pom1 drives F-BAR protein Cdc15 from the membrane to promote medial division
- (2020) Rahul Bhattacharjee et al. MOLECULAR BIOLOGY OF THE CELL
- Structure–Activity Relationships and Biological Evaluation of 7-Substituted Harmine Analogs for Human β-Cell Proliferation
- (2020) Kunal Kumar et al. MOLECULES
- The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo
- (2020) L. Trovò et al. NEUROBIOLOGY OF DISEASE
- Identification of a small molecule that stimulates human β-cell proliferation and insulin secretion, and protects against cytotoxic stress in rat insulinoma cells
- (2020) Hans E. Hohmeier et al. PLoS One
- Molecular dissection of chagas induced cardiomyopathy reveals central disease associated and druggable signaling pathways
- (2020) Jacob M. Wozniak et al. PLoS Neglected Tropical Diseases
- An atypical DYRK kinase connects quorum-sensing with posttranscriptional gene regulation in Trypanosoma brucei
- (2020) Mathieu Cayla et al. eLife
- Lorecivivint, a Novel Intra‐articular CLK/DYRK1A Inhibitor and Wnt Pathway Modulator for Treatment of Knee Osteoarthritis: A Phase 2 Randomized Trial
- (2020) Yusuf Yazici et al. Arthritis & Rheumatology
- Low UV-C stress modulates Chlamydomonas reinhardtii biomass composition and oxidative stress response through proteomic and metabolomic changes involving novel signalers and effectors
- (2020) Francisco Colina et al. Biotechnology for Biofuels
- A Dual Inhibitor of DYRK1A and GSK3β for β‐Cell Proliferation: Aminopyrazine Derivative GNF4877
- (2020) Yahu A. Liu et al. ChemMedChem
- Simplified detection of polyhistidine-tagged proteins in gels and membranes using a UV-excitable dye and a multiple chelator head pair
- (2020) Vlad-Stefan Raducanu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism
- (2020) Qingxin Zhou et al. JOURNAL OF EXPERIMENTAL MEDICINE
- DFG-1 residue controls inhibitor binding mode and affinity providing a basis for rational design of kinase inhibitor selectivity
- (2020) Martin Schröder et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of Potent PfCLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials
- (2020) Amit Mahindra et al. JOURNAL OF MEDICINAL CHEMISTRY
- Proline Hydroxylation Primes Protein Kinases for Autophosphorylation and Activation
- (2020) Sang Bae Lee et al. MOLECULAR CELL
- Selective DYRK1A Inhibitor for the Treatment of Neurodegenerative Diseases: Alzheimer, Parkinson, Huntington, and Down Syndrome
- (2020) Robert B. Kargbo ACS Medicinal Chemistry Letters
- Multi-layered proteomic analyses decode compositional and functional effects of cancer mutations on kinase complexes
- (2020) Martin Mehnert et al. Nature Communications
- Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice
- (2020) Charles R. Goodlett et al. Scientific Reports
- Mitochondrial Stress–Mediated Targeting of Quiescent Cancer Stem Cells in Oral Squamous Cell Carcinoma
- (2020) Tajindra Singh Saluja et al. Cancer Management and Research
- Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors
- (2020) Manuel Saldivia et al. Nature Microbiology
- The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities
- (2020) Jacopo Boni et al. Cancers
- DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis
- (2020) Amina Jamal Laham et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cells
- (2020) Chun Shik Park et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- MicroRNA‐215‐5p inhibits the proliferation of keratinocytes and alleviates psoriasis‐like inflammation by negatively regulating DYRK1A and its downstream signalling pathways
- (2020) Aimin Liu et al. EXPERIMENTAL DERMATOLOGY
- The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma
- (2020) Zhile Bai et al. GENE
- Cdc-Like Kinases (CLKs): Biology, Chemical Probes, and Therapeutic Potential
- (2020) Paula Martín Moyano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synergistic apoptotic effects in cancer cells by the combination of CLK and Bcl-2 family inhibitors
- (2020) Aiko Murai et al. PLoS One
- The stress-responsive kinase DYRK2 activates heat shock factor 1 promoting resistance to proteotoxic stress
- (2020) Rita Moreno et al. CELL DEATH AND DIFFERENTIATION
- More than a zip code: global modulation of cellular function by nuclear localization signals
- (2020) Chih‐Chia Chang et al. FEBS Journal
- Protein phosphatase PPM1B inhibits DYRK1A kinase through dephosphorylation of pS258 and reduces toxic tau aggregation
- (2020) Ye Hyung Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Emerging roles of DYRK2 in cancer
- (2020) Vasudha Tandon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- How to Separate Kinase Inhibition from Undesired Monoamine Oxidase A Inhibition—The Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine
- (2020) Anne Wurzlbauer et al. MOLECULES
- Expression, purification and crystallization of CLK1 kinase – A potential target for antiviral therapy
- (2020) Noa Dekel et al. PROTEIN EXPRESSION AND PURIFICATION
- Minibrain-related kinase/dual-specificity tyrosine-regulated kinase 1B implication in stem/cancer stem cells biology
- (2020) Nikolaos Kokkorakis et al. World Journal of Stem Cells
- Transcriptional response of human articular chondrocytes treated with fibronectin fragments: an in vitro model of the osteoarthritis phenotype
- (2020) K.S.M. Reed et al. OSTEOARTHRITIS AND CARTILAGE
- Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice
- (2019) Benoît Souchet et al. Acta Neuropathologica Communications
- Properties of FDA-approved small molecule protein kinase inhibitors
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- A complex between DYRK1A and DCAF7 phosphorylates the C-terminal domain of RNA polymerase II to promote myogenesis
- (2019) Dan Yu et al. NUCLEIC ACIDS RESEARCH
- New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis
- (2019) Helmi Tazarki et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Nuclear import of the DSCAM‐cytoplasmic domain drives signaling capable of inhibiting synapse formation
- (2019) Sonja M Sachse et al. EMBO JOURNAL
- A TOR-YAK1 signaling axis controls cell cycle, meristem activity and plant growth in Arabidopsis
- (2019) Adam Barrada et al. DEVELOPMENT
- Dyrk3 loss activates the purine metabolism and promotes hepatocellular carcinoma progression
- (2019) Fei Ma et al. HEPATOLOGY
- Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer
- (2019) Shiho Yokoyama-Mashima et al. CANCER LETTERS
- Chronic Dyrk1 Inhibition Delays the Onset of AD-Like Pathology in 3xTg-AD Mice
- (2019) R. Velazquez et al. MOLECULAR NEUROBIOLOGY
- Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment
- (2019) V. Deshmukh et al. OSTEOARTHRITIS AND CARTILAGE
- The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair
- (2019) Steven E. Guard et al. Scientific Reports
- A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response
- (2019) Julia Roewenstrunk et al. Scientific Reports
- Mutations of the AtYAK1 Kinase Suppress TOR Deficiency in Arabidopsis
- (2019) Céline Forzani et al. Cell Reports
- Regulation of influenza A virus mRNA splicing by CLK1
- (2019) Anita Artarini et al. ANTIVIRAL RESEARCH
- KLF4 Represses DYRK2 Inhibition of Self-renewal and Survival Through c-Myc and p53 in Leukemia Stem/Progenitor Cells
- (2019) Chun Shik Park et al. BLOOD
- The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models
- (2019) Betty Y. Tam et al. CANCER LETTERS
- Multiple functions of DYRK2 in cancer and tissue development
- (2019) Saishu Yoshida et al. FEBS LETTERS
- Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target
- (2019) Mahmood M. Alam et al. SCIENCE
- Upregulated Expression of MicroRNA-204-5p Leads to the Death of Dopaminergic Cells by Targeting DYRK1A-Mediated Apoptotic Signaling Cascade
- (2019) Ching-Chi Chiu et al. Frontiers in Cellular Neuroscience
- Structural Basis for the Selective Inhibition of Cdc2-Like Kinases by CX-4945
- (2019) Joo Youn Lee et al. Biomed Research International
- DYRK1A aggravates β cell dysfunction and apoptosis by promoting the phosphorylation and degradation of IRS2
- (2019) Mei Lu et al. EXPERIMENTAL GERONTOLOGY
- [b]-Annulated Halogen-Substituted Indoles as Potential DYRK1A Inhibitors
- (2019) Christian Lechner et al. MOLECULES
- Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression
- (2019) Sourav Banerjee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CLK3 Is A Direct Target Of miR-144 And Contributes To Aggressive Progression In Hepatocellular Carcinoma
- (2019) Hua Li et al. OncoTargets and Therapy
- Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling
- (2019) Steven E. Guard et al. Jove-Journal of Visualized Experiments
- Licocoumarone induces BxPC-3 pancreatic adenocarcinoma cell death by inhibiting DYRK1A
- (2019) Chao Zhao et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The Dual-Specificity Kinase DYRK1A Modulates the Levels of Cyclin L2 To Control HIV Replication in Macrophages
- (2019) Javan K. Kisaka et al. JOURNAL OF VIROLOGY
- Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
- (2019) Mike A Nalls et al. LANCET NEUROLOGY
- Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Sequential phosphorylation of NDEL1 by the DYRK2-GSK3β complex is critical for neuronal morphogenesis
- (2019) Youngsik Woo et al. eLife
- Anti-influenza effect and action mechanisms of the chemical constituent gallocatechin-7-gallate from Pithecellobium clypearia Benth
- (2018) Chao Li et al. ACTA PHARMACOLOGICA SINICA
- Halogen-Aromatic π Interactions Modulate Inhibitor Residence Times
- (2018) Christina Heroven et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells
- (2018) Elizabeth Bowler et al. BMC CANCER
- X-ray structures and feasibility assessment of CLK2 inhibitors for Phelan McDermid syndrome
- (2018) Andreas Markus Lerchner et al. ChemMedChem
- Synthesis and Evaluation of the Anticancer and Trypanocidal Activities of Boronic Tyrphostins
- (2018) Noemi de J. Hiller et al. ChemMedChem
- Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability
- (2018) Kenichi Iwai et al. EMBO Molecular Medicine
- CLK2 blockade modulates alternative splicing compromising MYC‐driven breast tumors
- (2018) Fernando Salvador et al. EMBO Molecular Medicine
- Autoregulation of the human splice factor kinase CLK1 through exon skipping and intron retention
- (2018) Simon Uzor et al. GENE
- Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics
- (2018) Dnyandev B. Jarhad et al. JOURNAL OF MEDICINAL CHEMISTRY
- Crystal Structure of Human Dual-Specificity Tyrosine-Regulated Kinase 3 Reveals New Structural Features and Insights into its Auto-phosphorylation
- (2018) Kuglae Kim et al. JOURNAL OF MOLECULAR BIOLOGY
- Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK2 Inhibitor for Treatment of Triple-negative Breast Cancer with a Compromised G1/S Checkpoint
- (2018) Dan Zhu et al. MOLECULAR CANCER THERAPEUTICS
- Kinase inhibitors: the road ahead
- (2018) Fleur M. Ferguson et al. NATURE REVIEWS DRUG DISCOVERY
- Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene
- (2018) Susana García-Cerro et al. NEUROBIOLOGY OF DISEASE
- Up-regulation of Dyrk1b promote astrocyte activation following lipopolysaccharide-induced neuroinflammation
- (2018) Mingqing He et al. NEUROPEPTIDES
- Alzheimer’s disease susceptibility genes modify the risk of Parkinson disease and Parkinson’s disease-associated cognitive impairment
- (2018) Lu Fang et al. NEUROSCIENCE LETTERS
- A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee
- (2018) V. Deshmukh et al. OSTEOARTHRITIS AND CARTILAGE
- Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype
- (2018) Anne Walter et al. PLoS One
- DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives
- (2018) Fernanda Neumann et al. Scientific Reports
- Functional characterization of DYRK1A missense variants associated with a syndromic form of intellectual deficiency and autism
- (2018) Esti Wahyu Widowati et al. Biology Open
- Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A
- (2018) Thu Lan Nguyen et al. Disease Models & Mechanisms
- DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective
- (2018) Ankita Pathak et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors
- (2018) Anna Czarna et al. JOURNAL OF MEDICINAL CHEMISTRY
- Kinase-controlled phase transition of membraneless organelles in mitosis
- (2018) Arpan Kumar Rai et al. NATURE
- DYRK1A and cognition: A lifelong relationship
- (2018) Maria L. Arbones et al. PHARMACOLOGY & THERAPEUTICS
- Furo[3,2-b ]pyridine: A Privileged Scaffold for Highly Selective Kinase Inhibitors and Effective Modulators of the Hedgehog Pathway
- (2018) Václav Němec et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Short-term administration of iso-α-acids increases transthyretin transcription in the hippocampus
- (2018) Takafumi Fukuda et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells
- (2018) Peng Wang et al. Cell Metabolism
- DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth
- (2018) Jeroni Luna et al. GUT
- Human cytomegalovirus utilises cellular dual-specificity tyrosine phosphorylation-regulated kinases during placental replication
- (2018) Stuart T. Hamilton et al. PLACENTA
- ANGUSTIFOLIA Regulates Actin Filament Alignment for Nuclear Positioning in Leaves
- (2018) Kosei Iwabuchi et al. PLANT PHYSIOLOGY
- DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B
- (2018) Mina Yousefelahiyeh et al. PLoS One
- Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature
- (2017) Thu Lan Nguyen et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- A wake-up call to quiescent cancer cells - potential use of DYRK1B inhibitors in cancer therapy
- (2017) Walter Becker FEBS Journal
- Structural analysis of pathogenic mutations in theDYRK1Agene in patients with developmental disorders
- (2017) Jochem M.G. Evers et al. HUMAN MOLECULAR GENETICS
- Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis
- (2017) Yingying Chen et al. HUMAN PATHOLOGY
- Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma
- (2017) Qingqing Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen
- (2017) Jennifer R. Riggs et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Potent and Selective Inhibitors of Cdc2-Like Kinase 1 (CLK1) as a New Class of Autophagy Inducers
- (2017) Qi-Zheng Sun et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clk1-regulated aerobic glycolysis is involved in glioma chemoresistance
- (2017) Li Zhang et al. JOURNAL OF NEUROCHEMISTRY
- Disease Association and Druggability of WD40 Repeat Proteins
- (2017) Richard Song et al. JOURNAL OF PROTEOME RESEARCH
- Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes
- (2017) Susana García-Cerro et al. NEUROBIOLOGY OF DISEASE
- Regulation of Glioma Cells Migration by DYRK2
- (2017) Yifen Shen et al. NEUROCHEMICAL RESEARCH
- Plant dual-specificity tyrosine phosphorylation-regulated kinase optimizes light-regulated growth and development in Arabidopsis
- (2017) Wen-Yu Huang et al. PLANT CELL AND ENVIRONMENT
- DYRK1A regulates Hap1–Dcaf7/WDR68 binding with implication for delayed growth in Down syndrome
- (2017) Jianxing Xiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The target landscape of clinical kinase drugs
- (2017) Susan Klaeger et al. SCIENCE
- Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cells
- (2017) Hua Chen et al. Oncotarget
- Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophy
- (2017) Yukiya Sako et al. Scientific Reports
- Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer’s disease
- (2017) N Janel et al. Translational Psychiatry
- Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits
- (2017) Megan Stringer et al. Molecular Genetics & Genomic Medicine
- Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice
- (2017) Xiaomin Yin et al. Scientific Reports
- Hyper-accumulation of starch and oil in a Chlamydomonas mutant affected in a plant-specific DYRK kinase
- (2016) Miriam Schulz-Raffelt et al. Biotechnology for Biofuels
- A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition
- (2016) Hyeongki Kim et al. Disease Models & Mechanisms
- Small-molecule kinase inhibitors: an analysis of FDA-approved drugs
- (2016) Peng Wu et al. DRUG DISCOVERY TODAY
- Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co–crystal structure
- (2016) Yannick J. Esvan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- DYRK1A inhibition as potential treatment for Alzheimer’s disease
- (2016) Silvia Stotani et al. Future Medicinal Chemistry
- Influence of prenatal EGCG treatment andDyrk1adosage reduction on craniofacial features associated with Down syndrome
- (2016) Samantha D. McElyea et al. HUMAN MOLECULAR GENETICS
- An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases
- (2016) Apirat Chaikuad et al. JOURNAL OF MEDICINAL CHEMISTRY
- The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome
- (2016) P Lee et al. LEUKEMIA
- An ID2-dependent mechanism for VHL inactivation in cancer
- (2016) Sang Bae Lee et al. NATURE
- Association of DYRK1A polymorphisms with sporadic Parkinson’s disease in Chinese Han population
- (2016) Luan Cen et al. NEUROSCIENCE LETTERS
- Wdr68 Mediates Dorsal and Ventral Patterning Events for Craniofacial Development
- (2016) Estibaliz Alvarado et al. PLoS One
- CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency
- (2016) Michael Bidinosti et al. SCIENCE
- Selective inhibition of the kinase DYRK1A by targeting its folding process
- (2016) Isao Kii et al. Nature Communications
- Cdc2-like kinase 2 is a key regulator of the cell cycle via FOXO3a/p27 in glioblastoma
- (2016) Soon Young Park et al. Oncotarget
- DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance
- (2016) Wolfgang Gruber et al. Oncotarget
- A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma
- (2016) Aneesha Radhakrishnan et al. Scientific Reports
- DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
- (2016) Arnaud Duchon et al. Frontiers in Behavioral Neuroscience
- An extensive program of periodic alternative splicing linked to cell cycle progression
- (2016) Daniel Dominguez et al. eLife
- The adaptor protein DCAF7 mediates the interaction of the adenovirus E1A oncoprotein with the protein kinases DYRK1A and HIPK2
- (2016) Florian Glenewinkel et al. Scientific Reports
- CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer
- (2015) T. Yoshida et al. CANCER RESEARCH
- A Human Interactome in Three Quantitative Dimensions Organized by Stoichiometries and Abundances
- (2015) Marco Y. Hein et al. CELL
- The BioPlex Network: A Systematic Exploration of the Human Interactome
- (2015) Edward L. Huttlin et al. CELL
- DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies
- (2015) Jianling Ji et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25–35 peptide administration in mice
- (2015) Gaëlle Naert et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Arabidopsis Yak1 protein (AtYak1) is a dual specificity protein kinase
- (2015) Dongjin Kim et al. FEBS LETTERS
- Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomicDyrk1a
- (2015) Joshua D. Blazek et al. HUMAN MOLECULAR GENETICS
- Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I
- (2015) Nana Jin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A
- (2015) Hannes Falke et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity
- (2015) Eunju Im et al. JOURNAL OF NEUROCHEMISTRY
- A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologiesin vitro
- (2015) Séverine Coutadeur et al. JOURNAL OF NEUROCHEMISTRY
- Quantitative Phosphoproteomics Reveals Pathways for Coordination of Cell Growth and Division by the Conserved Fission Yeast Kinase Pom1
- (2015) Arminja N. Kettenbach et al. MOLECULAR & CELLULAR PROTEOMICS
- Drug Discovery of Host CLK1 Inhibitors for Influenza Treatment
- (2015) Mian Zu et al. MOLECULES
- A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication
- (2015) Peng Wang et al. NATURE MEDICINE
- A historical overview of protein kinases and their targeted small molecule inhibitors
- (2015) Robert Roskoski PHARMACOLOGICAL RESEARCH
- DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications
- (2015) Ramzi Abbassi et al. PHARMACOLOGY & THERAPEUTICS
- FDA-approved small-molecule kinase inhibitors
- (2015) Peng Wu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Inhibition of DYRK1A and GSK3B induces human β-cell proliferation
- (2015) Weijun Shen et al. Nature Communications
- Role of dual specificity tyrosine-phosphorylation-regulated kinase 1B (Dyrk1B) in S-phase entry of HPV E7 expressing cells from quiescence
- (2015) Na Zhou et al. Oncotarget
- The structure of a dual-specificity tyrosine phosphorylation-regulated kinase 1A–PKC412 complex reveals disulfide-bridge formation with the anomalous catalytic loop HRD(HCD) cysteine
- (2015) Marina Alexeeva et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- DYRK1A Controls HIV-1 Replication at a Transcriptional Level in an NFAT Dependent Manner
- (2015) Thijs Booiman et al. PLoS One
- DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies
- (2014) Walter Becker et al. CNS & Neurological Disorders-Drug Targets
- DYRK1A phoshorylates histone H3 to differentially regulate the binding of HP1 isoforms and antagonize HP1-mediated transcriptional repression
- (2014) S. M. Jang et al. EMBO REPORTS
- The Molecular Chaperone TRiC/CCT Binds to the Trp-Asp 40 (WD40) Repeat Protein WDR68 and Promotes Its Folding, Protein Kinase DYRK1A Binding, and Nuclear Accumulation
- (2014) Yoshihiko Miyata et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of the SR Protein-Phosphorylating CLK Kinases of Plasmodium falciparum Impairs Blood Stage Replication and Malaria Transmission
- (2014) Selina Kern et al. PLoS One
- Overexpression of Dyrk1A Is Implicated in Several Cognitive, Electrophysiological and Neuromorphological Alterations Found in a Mouse Model of Down Syndrome
- (2014) Susana García-Cerro et al. PLoS One
- Pyrido[2,3-d]pyrimidines: Discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors
- (2013) Kevin Anderson et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Dual Specificity Kinase DYRK3 Couples Stress Granule Condensation/Dissolution to mTORC1 Signaling
- (2013) Frank Wippich et al. CELL
- A novel link of HLA locus to the regulation of immunity and infection: NFKBIL1 regulates alternative splicing of human immune-related genes and influenza virus M gene
- (2013) Jianbo An et al. JOURNAL OF AUTOIMMUNITY
- Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth
- (2013) Natividad Pozo et al. JOURNAL OF CLINICAL INVESTIGATION
- Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans
- (2013) Rafael De la Torre et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Wdr68 Requires Nuclear Access for Craniofacial Development
- (2013) Bingyan Wang et al. PLoS One
- Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs
- (2013) Abhijeet Bakre et al. PLoS One
- Structures of Down Syndrome Kinases, DYRKs, Reveal Mechanisms of Kinase Activation and Substrate Recognition
- (2013) Meera Soundararajan et al. STRUCTURE
- The Protein Interaction Landscape of the Human CMGC Kinase Group
- (2013) Markku Varjosalo et al. Cell Reports
- Dyrk kinases regulate phosphorylation of doublecortin, cytoskeletal organization, and neuronal morphology
- (2012) Tatiana I. Slepak et al. Cytoskeleton
- Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A (Dyrk1A) Modulates Serine/Arginine-rich Protein 55 (SRp55)-promoted Tau Exon 10 Inclusion
- (2012) Xiaomin Yin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DYRK1A in Down syndrome: an oncogene or tumor suppressor?
- (2012) Yehudit Birger et al. JOURNAL OF CLINICAL INVESTIGATION
- Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome
- (2012) Sébastien Malinge et al. JOURNAL OF CLINICAL INVESTIGATION
- Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B
- (2012) Tania Tahtouh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome
- (2012) Xavier Altafaj et al. NEUROBIOLOGY OF DISEASE
- A Pilot Study Examining Associations between DYRK1A and a-Synuclein Dementias
- (2012) Emma L. Jones et al. Neurodegenerative Diseases
- Library-based Discovery of DYRK1A/CLK1 Inhibitors from Natural Product Extracts
- (2012) Patrick Grabher et al. PLANTA MEDICA
- Deep Evolutionary Conservation of an Intramolecular Protein Kinase Activation Mechanism
- (2012) Jingfen Han et al. PLoS One
- Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases
- (2012) Vassilios Myrianthopoulos et al. ACS Medicinal Chemistry Letters
- DYRK1A binds to an evolutionarily conserved WD40-repeat protein WDR68 and induces its nuclear translocation
- (2011) Yoshihiko Miyata et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Two key genes closely implicated with the neuropathological characteristics in Down syndrome: DYRK1A and RCAN1
- (2011) Joong-Kyu Park et al. BMB Reports
- Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing
- (2011) Oleg Fedorov et al. CHEMISTRY & BIOLOGY
- Two nucleus-localized CDK-like kinases with crucial roles for malaria parasite erythrocytic replication are involved in phosphorylation of splicing factor
- (2011) Shruti Agarwal et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Leucettines, a Class of Potent Inhibitors of cdc2-Like Kinases and Dual Specificity, Tyrosine Phosphorylation Regulated Kinases Derived from the Marine Sponge Leucettamine B: Modulation of Alternative Pre-RNA Splicing
- (2011) Mansour Debdab et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega
- (2011) F. Sievers et al. Molecular Systems Biology
- Genome-Wide Association Study Identifies Single Nucleotide Polymorphism in DYRK1A Associated with Replication of HIV-1 in Monocyte-Derived Macrophages
- (2011) Sebastiaan M. Bol et al. PLoS One
- Differential effect of CLK SR Kinases on HIV-1 gene expression: potential novel targets for therapy
- (2011) Raymond Wong et al. Retrovirology
- Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum
- (2011) Lev Solyakov et al. Nature Communications
- DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles
- (2010) Sergi Aranda et al. FASEB JOURNAL
- Activation, regulation, and inhibition of DYRK1A
- (2010) Walter Becker et al. FEBS Journal
- Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer’s disease
- (2010) Young Shin Ryu et al. JOURNAL OF NEUROCHEMISTRY
- Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication
- (2010) Alexander Karlas et al. NATURE
- Characterization of a Domain That Transiently Converts Class 2 DYRKs into Intramolecular Tyrosine Kinases
- (2010) R. Kinstrie et al. Science Signaling
- Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
- (2010) Yasushi Ogawa et al. Nature Communications
- Jalview Version 2--a multiple sequence alignment editor and analysis workbench
- (2009) A. M. Waterhouse et al. BIOINFORMATICS
- Synthesis and preliminary biological evaluation of new derivatives of the marine alkaloid leucettamine B as kinase inhibitors
- (2009) Mansour Debdab et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Kinase Domain Insertions Define Distinct Roles of CLK Kinases in SR Protein Phosphorylation
- (2009) Alex N. Bullock et al. STRUCTURE
- Genome-Wide Analysis of Histidine Repeats Reveals Their Role in the Localization of Human Proteins to the Nuclear Speckles Compartment
- (2009) Eulàlia Salichs et al. PLoS Genetics
- Targeting Dyrk1A with AAVshRNA Attenuates Motor Alterations in TgDyrk1A, a Mouse Model of Down Syndrome
- (2008) Jon Ortiz-Abalia et al. AMERICAN JOURNAL OF HUMAN GENETICS
- DYRK3 Dual-specificity Kinase Attenuates Erythropoiesis during Anemia
- (2008) Olga Bogacheva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Increased Dosage of Dyrk1A Alters Alternative Splicing Factor (ASF)-regulated Alternative Splicing of Tau in Down Syndrome
- (2008) Jianhua Shi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4
- (2008) J.H. Sitz et al. NEUROSCIENCE
- Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer’s disease
- (2007) Soo-Ryoon Ryoo et al. JOURNAL OF NEUROCHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started